Todd C. Girolamo - 13 Jan 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jan 2022, 15:04:55 UTC
Prior SEC filing
12 Jan 2022
Next SEC filing
22 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Todd C. Girolamo

Key filing fact

Todd C. Girolamo filed Form 4 for CALADRIUS BIOSCIENCES, INC. (LSTA) on 18 Jan 2022.

Key facts

  • This page summarizes Todd C. Girolamo's Form 4 filing for CALADRIUS BIOSCIENCES, INC. (LSTA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Jan 2022, 15:04.

Change

  • Previous filing in this sequence was filed on 12 Jan 2022.
  • Current net transaction value: -$3,837.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LSTA transaction

Common Stock

Tax liability

Transaction value
$2,067
Shares
-2,563
Change %
-1.5%
Price
$0.8063
Shares after
162,985
Date
13 Jan 2022
Ownership
Direct
Footnotes
F1, F2
LSTA transaction

Common Stock

Tax liability

Transaction value
$1,770
Shares
-2,158
Change %
-1.3%
Price
$0.8204
Shares after
160,827
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares withheld as payment of a tax liability on vesting of restricted stock.

Footnote F2

Includes 123,000 unvested restricted stock.

Footnote F3

Includes 119,000 unvested restricted stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .